Globular and protofibrillar Aβ aggregates impair neurotransmission by different mechanisms

Biochemistry

Volumn 52, Issue 8, 2013, Pages 1466-1476

  Moreth, Jens ^a   Kroker, Katja S ^a   Schwanzar, Daniel ^b   Schnack, Cathrin ^b   Von Arnim, Christine A F ^b   Hengerer, Bastian ^a   Rosenbrock, Holger ^a   Kussmaul, Lothar ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER'S DISEASE; BIOLOGICAL EFFECTS; CRITICAL ISSUES; DIFFERENT MECHANISMS; DIFFERENT PROTOCOLS; IONIC ENVIRONMENT; LONG-TERM POTENTIATIONS; METASTABILITIES; NANOMOLAR; NEUROTOXICITY; STRUCTURAL CONVERSION; STRUCTURAL REARRANGEMENT; SYNTHETIC PEPTIDE; TIME-DEPENDENT;

NEURONS; PEPTIDES;

AGGREGATES;

AMYLOID BETA PROTEIN; GLOBULAR PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LONG TERM CARE; MALE; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN STABILITY; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CELLS, CULTURED; HIPPOCAMPUS; HUMANS; MALE; MICE; MICE, INBRED C57BL; NEURONS; RATS; RATS, WISTAR; SYNAPTIC TRANSMISSION;

EID: 84874431342     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi3016444     Document Type: Article

References (78)

1. Selkoe, D. J. (2001) Alzheimer's Disease: Genes, Proteins, and Therapy Physiol. Rev. 81, 741-766
2. Broersen, K., Rousseau, F., and Schymkowitz, J. (2010) The culprit behind amyloid β peptide related neurotoxicity in Alzheimer's disease: Oligomer size or conformation? Alzheimer's Res. Ther. 2, 12
3. Haass, C. (2004) Take five: BACE and the γ-secretase quartet conduct Alzheimer's amyloid β-peptide generation EMBO J. 23, 483-488
4. Mc Donald, J. M., Savva, G. M., Brayne, C., Welzel, A. T., Forster, G., Shankar, G. M., Selkoe, D. J., Ince, P. G., and Walsh, D. M. (2010) The presence of sodium dodecyl sulphate-stable A dimers is strongly associated with Alzheimer-type dementia Brain 133, 1328-1341 (on behalf of the Medical Research Council Cognitive Function and Ageing Study)
5. Terry, R. D. (2006) Alzheimer's Disease and the Aging Brain Journal of Geriatric Psychiatry and Neurology 19, 125-128
6. Walsh, D. M. and Selkoe, D. J. (2007) Aβ oligomers: A decade of discovery J. Neurochem. 101, 1172-1184
7. Benilova, I., Karran, E., and De Strooper, B. (2012) The toxic Aβ oligomer and Alzheimer's disease: An emperor in need of clothes Nat. Neurosci. 15, 349-357
8. Bitan, G., Fradinger, E. A., Spring, S. M., and Teplow, D. B. (2005) Neurotoxic protein oligomers: What you see is not always what you get Amyloid 12, 88-95
9. Hepler, R. W., Grimm, K. M., Nahas, D. D., Breese, R., Dodson, E. C., Acton, P., Keller, P. M., Yeager, M., Wang, H., Shughrue, P., Kinney, G., and Joyce, J. G. (2006) Solution State Characterization of Amyloid β-Derived Diffusible Ligands Biochemistry 45, 15157-15167
10. Stine, W. B. (2002) In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis J. Biol. Chem. 278, 11612-11622
11. Mastrangelo, I. A., Ahmed, M., Sato, T., Liu, W., Wang, C., Hough, P., and Smith, S. O. (2006) High-resolution Atomic Force Microscopy of Soluble Aβ42 Oligomers J. Mol. Biol. 358, 106-119
12. Rahimi, F., Shanmugam, A., and Bitan, G. (2008) Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders Curr. Alzheimer Res. 5, 319-341
13. Fezoui, Y., Hartley, D. M., Harper, J. D., Khurana, R., Walsh, D. M., Condron, M. M., Selkoe, D. J., Lansbury, P. T., Fink, A. L., and Teplow, D. B. (2000) An improved method of preparing the amyloid β-protein for fibrillogenesis and neurotoxicity experiments Amyloid 7, 166-178
14. Bitan, G. (2002) Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways Proc. Natl. Acad. Sci. U.S.A. 100, 330-335
15. Kuperstein, I., Broersen, K., Benilova, I., Rozenski, J., Jonckheere, W., Debulpaep, M., Vandersteen, A., Segers-Nolten, I., Van Der Werf, K., Subramaniam, V., Braeken, D., Callewaert, G., Bartic, C., D'Hooge, R., Martins, I. C., Rousseau, F., Schymkowitz, J., and De Strooper, B. (2010) Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio EMBO J. 29, 3408-3420
16. Necula, M., Kayed, R., Milton, S., and Glabe, C. G. (2007) Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and Distinct J. Biol. Chem. 282, 10311-10324
17. Roychaudhuri, R., Yang, M., Hoshi, M. M., and Teplow, D. B. (2009) Amyloid β-protein assembly and Alzheimer disease J. Biol. Chem. 284, 4749-4753
18. Martins, I. C., Kuperstein, I., Wilkinson, H., Maes, E., Vanbrabant, M., Jonckheere, W., Van Gelder, P., Hartmann, D., D'Hooge, R., De Strooper, B., Schymkowitz, J., and Rousseau, F. (2007) Lipids revert inert Aβ amyloid fibrils to neurotoxic protofibrils that affect learning in mice EMBO J. 27, 224-233
19. Ahmed, M., Davis, J., Aucoin, D., Sato, T., Ahuja, S., Aimoto, S., Elliott, J. I., Van Nostrand, W. E., and Smith, S. O. (2010) Structural conversion of neurotoxic amyloid-β(1-42) oligomers to fibrils Nat. Struct. Mol. Biol. 17, 561-567
20. O'Nuallain, B., Freir, D. B., Nicoll, A. J., Risse, E., Ferguson, N., Herron, C. E., Collinge, J., and Walsh, D. M. (2010) Amyloid β-Protein Dimers Rapidly Form Stable Synaptotoxic Protofibrils J. Neurosci. 30, 14411-14419
21. Haass, C. (2010) Initiation and propagation of neurodegeneration Nat. Med. 16, 1201-1204
22. Lomakin, A. and Teplow, D. B. (2006) Quasielastic light scattering study of amyloid β-protein fibril formation Protein Pept. Lett. 13, 247-254
23. Zattoni, A., Rambaldi, D. C., Reschiglian, P., Melucci, M., Krol, S., Garcia, A. M. C., Sanz-Medel, A., Roessner, D., and Johann, C. (2009) Asymmetrical flow field-flow fractionation with multi-angle light scattering detection for the analysis of structured nanoparticles J. Chromatogr., A 1216, 9106-9112
24. Fraunhofer, W. and Winter, G. (2004) The use of asymmetrical flow field-flow fractionation in pharmaceutics and biopharmaceutics Eur. J. Pharm. Biopharm. 58, 369-383
25. Cremona, M., Mauricio, M., Scavarda Do Carmo, L. C., Prioli, R., Nunes, V., Zanette, S., Caride, A., and Albuquerque, M. (2000) Grain size distribution analysis in polycrystalline LiF thin films by mathematical morphology techniques on AFM images and X-ray diffraction data J. Microsc. 197, 260-267
26. Brewer, G. J., Torricelli, J. R., Evege, E. K., and Price, P. J. (1993) Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serum-free medium combination J. Neurosci. Res. 35, 567-576
27. Lacor, P. N. (2004) Synaptic Targeting by Alzheimer's-Related Amyloid Oligomers J. Neurosci. 24, 10191-10200
28. Kroker, K. S., Rosenbrock, H., and Rast, G. (2011) A multi-slice recording system for stable late phase hippocampal long-term potentiation experiments J. Neurosci. Methods 194, 394-401
29. Collingridge, G. L., Kehl, S. J., Loo, R., and McLennan, H. (1983) Effects of kainic and other amino acids on synaptic excitation in rat hippocampal slices: 1. Extracellular analysis Exp. Brain Res. 52, 170-178
30. Hardy, J. and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics Science 297, 353-356
31. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., Wals, P., Zhang, C., Finch, C. E., Krafft, G. A., and Klein, W. L. (1998) Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins Proc. Natl. Acad. Sci. U.S.A. 95, 6448-6453
32. Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., and Strittmatter, S. M. (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers Nature 457, 1128-1132
33. Balducci, C., Beeg, M., Stravalaci, M., Bastone, A., Sclip, A., Biasini, E., Tapella, L., Colombo, L., Manzoni, C., Borsello, T., Chiesa, R., Gobbi, M., Salmona, M., and Forloni, G. (2010) Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein Proc. Natl. Acad. Sci. U.S.A. 107, 2295-2300
34. Bitan, G., Vollers, S. S., and Teplow, D. B. (2003) Elucidation of primary structure elements controlling early amyloid β-protein oligomerization J. Biol. Chem. 278, 34882-34889
35. Chromy, B. A., Nowak, R. J., Lambert, M. P., Viola, K. L., Chang, L., Velasco, P. T., Jones, B. W., Fernandez, S. J., Lacor, P. N., Horowitz, P., Finch, C. E., Krafft, G. A., and Klein, W. L. (2003) Self-Assembly of Aβ 1-42 into Globular Neurotoxins Biochemistry 42, 12749-12760
36. Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., and Teplow, D. B. (1999) Amyloid β-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates J. Biol. Chem. 274, 25945-25952
37. Hartley, D. M., Walsh, D. M., Ye, C. P., Diehl, T., Vasquez, S., Vassilev, P. M., Teplow, D. B., and Selkoe, D. J. (1999) Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons J. Neurosci. 19, 8876-8884
38. Itkin, A., Dupres, V., Dufreîne, Y. F., Bechinger, B., Ruysschaert, J.-M., and Raussens, V. (2011) Calcium Ions Promote Formation of Amyloid β-Peptide (1-40) Oligomers Causally Implicated in Neuronal Toxicity of Alzheimer's Disease PLoS One 6, e18250
39. Wogulis, M. (2005) Nucleation-Dependent Polymerization Is an Essential Component of Amyloid-Mediated Neuronal Cell Death J. Neurosci. 25, 1071-1080
40. Jan, A., Adolfsson, O., Allaman, I., Buccarello, A. L., Magistretti, P. J., Pfeifer, A., Muhs, A., and Lashuel, H. A. (2011) Aβ42 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete Aβ42 species J. Biol. Chem. 286, 8585-8596
41. Ono, K., Condron, M. M., and Teplow, D. B. (2009) Structure-neurotoxicity relationships of amyloid β-protein oligomers Proc. Natl. Acad. Sci. U.S.A. 106, 14745-14750
42. Kessels, H. W., Nguyen, L. N., Nabavi, S., and Malinow, R. (2010) The prion protein as a receptor for amyloid-β Nature 466, E3-E4
43. De Felice, F. G., Wu, D., Lambert, M. P., Fernandez, S. J., Velasco, P. T., Lacor, P. N., Bigio, E. H., Jerecic, J., Acton, P. J., Shughrue, P. J., Chen-Dodson, E., Kinney, G. G., and Klein, W. L. (2008) Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers Neurobiol. Aging 29, 1334-1347
44. Lacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., and Klein, W. L. (2007) A Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease J. Neurosci. 27, 796-807
45. Deshpande, A. (2006) Different Conformations of Amyloid β Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons J. Neurosci. 26, 6011-6018
46. Shughrue, P. J., Acton, P. J., Breese, R. S., Zhao, W. Q., Chen-Dodson, E., Hepler, R. W., Wolfe, A. L., Matthews, M., Heidecker, G. J., Joyce, J. G., Villarreal, S. A., and Kinney, G. G. (2010) Anti-ADDL antibodies differentially block oligomer binding to hippocampal neurons Neurobiol. Aging 31, 189-202
47. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., and Selkoe, D. J. (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo Nature 416, 535-539
48. Wang, Q. (2004) Block of Long-Term Potentiation by Naturally Secreted and Synthetic Amyloid β-Peptide in Hippocampal Slices Is Mediated via Activation of the Kinases c-Jun N-Terminal Kinase, Cyclin-Dependent Kinase 5, and p38 Mitogen-Activated Protein Kinase as well as Metabotropic Glutamate Receptor Type 5 J. Neurosci. 24, 3370-3378
49. Dingledine, R., Borges, K., Bowie, D., and Traynelis, S. F. (1999) The glutamate receptor ion channels Pharmacol. Rev. 51, 7-61
50. Harris, E. W., Ganong, A. H., and Cotman, C. W. (1984) Long-term potentiation in the hippocampus involves activation of N-methyl- d -aspartate receptors Brain Res. 323, 132-137
51. Collingridge, G. L. (2003) The induction of N-methyl- d -aspartate receptor-dependent long-term potentiation Philos. Trans. R. Soc. B 358, 635-641
52. Kroker, K. S., Rast, G., and Rosenbrock, H. (2011) Differential effect of the mGlu5 receptor positive allosteric modulator ADX-47273 on early and late hippocampal LTP Neuropharmacology 61, 707-714
53. Muller, D., Joly, M., and Lynch, G. (1988) Contributions of quisqualate and NMDA receptors to the induction and expression of LTP Science 242, 1694-1697
54. Watt, A. J., Sjöström, P. J., Häusser, M., Nelson, S. B., and Turrigiano, G. G. (2004) A proportional but slower NMDA potentiation follows AMPA potentiation in LTP Nat. Neurosci. 7, 518-524
55. Yamin, G. (2009) NMDA receptor-dependent signaling pathways that underlie amyloid β-protein disruption of LTP in the hippocampus J. Neurosci. Res. 87, 1729-1736
56. Hartley, D. M., Zhao, C., Speier, A. C., Woodard, G. A., Li, S., Li, Z., and Walz, T. (2008) Transglutaminase induces protofibril-like amyloid β-protein assemblies that are protease-resistant and inhibit long-term potentiation J. Biol. Chem. 283, 16790-16800
57. Wang, H.-W., Pasternak, J. F., Kuo, H., Ristic, H., Lambert, M. P., Chromy, B., Viola, K. L., Klein, W. L., Stine, W. B., Krafft, G. A., and Trommer, B. L. (2002) Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus Brain Res. 924, 133-140
58. Viola, K. L., Velasco, P. T., and Klein, W. L. (2008) Why Alzheimer's is a disease of memory: The attack on synapses by Aβ oligomers (ADDLs) J. Nutr., Health Aging 12, 51S-7S
59. Renner, M., Lacor, P. N., Velasco, P. T., Xu, J., Contractor, A., Klein, W. L., and Triller, A. (2010) Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5 Neuron 66, 739-754
60. Collett, V. J. and Collingridge, G. L. (2004) Interactions between NMDA receptors and mGlu5 receptors expressed in HEK293 cells Br. J. Pharmacol. 142, 991-1001
61. Khosravani, H., Zhang, Y., Tsutsui, S., Hameed, S., Altier, C., Hamid, J., Chen, L., Villemaire, M., Ali, Z., Jirik, F. R., and Zamponi, G. W. (2008) Prion protein attenuates excitotoxicity by inhibiting NMDA receptors J. Cell Biol. 181, 551-565
62. Roselli, F. (2005) Soluble β-Amyloid1-40 Induces NMDA-Dependent Degradation of Postsynaptic Density-95 at Glutamatergic Synapses J. Neurosci. 25, 11061-11070
63. Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., and Malinow, R. (2006) AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss Neuron 52, 831-843
64. Parameshwaran, K., Sims, C., Kanju, P., Vaithianathan, T., Shonesy, B. C., Dhanasekaran, M., Bahr, B. A., and Suppiramaniam, V. (2007) Amyloid β-peptide Aβ1-42 but not Aβ1-40 attenuates synaptic AMPA receptor function Synapse 61, 367-374
65. 2+/calmodulin-dependent protein kinase II synaptic distribution J. Biol. Chem. 284, 10639-10649
66. Mason, R. P., Jacob, R. F., Walter, M. F., Mason, P. E., Avdulov, N. A., Chochina, S. V., Igbavboa, U., and Wood, W. G. (1999) Distribution and fluidizing action of soluble and aggregated amyloid β-peptide in rat synaptic plasma membranes J. Biol. Chem. 274, 18801-18807
67. Kremer, J. J., Pallitto, M. M., Sklansky, D. J., and Murphy, R. M. (2000) Correlation of β-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes Biochemistry 39, 10309-10318
68. Eckert, G. P., Cairns, N. J., Maras, A., Gattaz, W. F., and Muller, W. E. (2000) Cholesterol modulates the membrane-disordering effects of β-amyloid peptides in the hippocampus: Specific changes in Alzheimer's disease Dementia Geriatr. Cognit. Disord. 11, 181-186
69. Michikawa, M., Gong, J. S., Fan, Q. W., Sawamura, N., and Yanagisawa, K. (2001) A novel action of Alzheimer's amyloid β-protein (Aβ): Oligomeric Aβ promotes lipid release J. Neurosci. 21, 7226-7235
70. Kagan, B. L., Azimov, R., and Azimova, R. (2004) Amyloid Peptide Channels J. Membr. Biol. 202, 1-10
71. Lashuel, H. A. and Lansbury, P. T. (2006) Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? Q. Rev. Biophys. 39, 167
72. Kayed, R., Sokolov, Y., Edmonds, B., McIntire, T. M., Milton, S. C., Hall, J. E., and Glabe, C. G. (2004) Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases J. Biol. Chem. 279, 46363-46366
73. Ashley, R. H., Harroun, T. A., Hauss, T., Breen, K. C., and Bradshaw, J. P. (2006) Autoinsertion of soluble oligomers of Alzheimer's Aβ(1-42) peptide into cholesterol-containing membranes is accompanied by relocation of the sterol towards the bilayer surface BMC Struct. Biol. 6, 21
74. Subasinghe, S., Unabia, S., Barrow, C. J., Mok, S. S., Aguilar, M. I., and Small, D. H. (2003) Cholesterol is necessary both for the toxic effect of Aβ peptides on vascular smooth muscle cells and for Aβ binding to vascular smooth muscle cell membranes J. Neurochem. 84, 471-479
75. Williams, T. L. and Serpell, L. C. (2011) Membrane and surface interactions of Alzheimer's Aβ peptide: Insights into the mechanism of cytotoxicity FEBS J. 278, 3905-3917
76. Verdier, Y., Zarándi, M., and Penke, B. (2004) Amyloid β-peptide interactions with neuronal and glial cell plasma membrane: Binding sites and implications for Alzheimer's disease J. Pept. Sci. 10, 229-248
77. Jurado, S. and Knafo, S. (2012) Microscale AMPAR reorganization and dynamics of the postsynaptic density J. Neurosci. 32, 7103-7105
78. Reed, M. N., Hofmeister, J. J., Jungbauer, L., Welzel, A. T., Yu, C., Sherman, M. A., Lesné, S., LaDu, M. J., Walsh, D. M., Ashe, K. H., and Cleary, J. P. (2011) Cognitive effects of cell-derived and synthetically derived Aβ oligomers Neurobiol. Aging 32, 1784-1794